Skip to main content

Advertisement

SpringerLink
Log in

Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM)

  • Consensus Statement
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Upadhyay A, Jaber BL, Madias NE (2006) Incidence and prevalence of hyponatremia. Am J Med 119(7 Suppl 1):S30–S35

    Article  CAS  PubMed  Google Scholar 

  2. Adrogue HJ, Madias NE (2000) Hyponatremia. N Engl J Med 342(21):1581–1589

    Article  CAS  PubMed  Google Scholar 

  3. Gill G, Huda B, Boyd A, Skagen K, Wile D, Watson I et al (2006) Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin Endocrinol (Oxf) 65(2):246–249

    Article  Google Scholar 

  4. Renneboog B, Musch W, Vandemergel X, Manto MU, Decaux G (2006) Mild chronic hyponatremia is associated with falls, unsteadiness, and attention deficits. Am J Med. 119(1):71e1–71e8

    Article  CAS  Google Scholar 

  5. Gankam Kengne F, Andres C, Sattar L, Melot C, Decaux G (2008) Mild hyponatremia and risk of fracture in the ambulatory elderly. QJM 101(7):583–588

    Article  CAS  PubMed  Google Scholar 

  6. Kinsella S, Moran S, Sullivan MO, Molloy MG, Eustace JA (2010) Hyponatremia independent of osteoporosis is associated with fracture occurrence. Clin J Am Soc Nephrol 5(2):275–280

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Verbalis JG, Barsony J, Sugimura Y, Tian Y, Adams DJ, Carter EA et al (2010) Hyponatremia-induced osteoporosis. J Bone Miner Res 25(3):554–563

    Article  CAS  PubMed  Google Scholar 

  8. Barsony J, Sugimura Y, Verbalis JG (2011) Osteoclast response to low extracellular sodium and the mechanism of hyponatremia-induced bone loss. J Biol Chem 286(12):10864–10875

    Article  CAS  PubMed  Google Scholar 

  9. Corona G, Giuliani C, Parenti G, Norello D, Verbalis JG, Forti G et al (2013) Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8(12):e80451

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  10. Corona G, Giuliani C, Parenti G, Colombo GL, Sforza A, Maggi M et al (2016) The economic burden of hyponatremia: systematic review and meta-analysis. Am J Med. 129(8):823e4–835e4

    Article  Google Scholar 

  11. Chambrey R, Trepiccione F (2015) Relative roles of principal and intercalated cells in the regulation of sodium balance and blood pressure. Curr Hypertens Rep 17(4):538

    Article  PubMed  CAS  Google Scholar 

  12. Cuesta M, Garrahy A, Thompson CJ (2016) SIAD: practical recommendations for diagnosis and management. J Endocrinol Invest 39(9):991–1001

    Article  CAS  PubMed  Google Scholar 

  13. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med 40(3):320–331

    Article  PubMed  Google Scholar 

  14. Verbalis JG, Goldsmith SR, Greenberg A, Korzelius C, Schrier RW, Sterns RH et al (2013) Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am J Med 126(10 Suppl 1):S1–S42

    Article  PubMed  Google Scholar 

  15. Hoorn EJ, Lindemans J, Zietse R (2006) Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 21(1):70–76

    Article  PubMed  Google Scholar 

  16. Rondon-Berrios H, Berl T (2016) Vasopressin receptor antagonists: characteristics and clinical role. Best Pract Res Clin Endocrinol Metab 30(2):289–303

    Article  CAS  PubMed  Google Scholar 

  17. Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D et al (2014) Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant 29(Suppl 2):i1–i39

    Article  PubMed  Google Scholar 

  18. Regolisti G, Cabassi A, Antonucci E, Brusasco I, Cademartiri C, Pistolesi V et al (2015) Hyponatremia in clinical practice. G Ital Nefrol 32(1)

  19. Aylwin S, Burst V, Peri A, Runkle I, Thatcher N (2015) ‘Dos and don’ts’ in the management of hyponatremia. Curr Med Res Opin 31(9):1755–1761

    Article  CAS  PubMed  Google Scholar 

  20. Glover DJ, Glick JH (1987) Metabolic oncologic emergencies. CA Cancer J Clin 37(5):302–320

    Article  CAS  PubMed  Google Scholar 

  21. Silverman P, Distelhorst CW (1989) Metabolic emergencies in clinical oncology. Semin Oncol 16(6):504–515

    CAS  PubMed  Google Scholar 

  22. Berghmans T, Paesmans M, Body JJ (2000) A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis. Support Care Cancer 8(3):192–197

    Article  CAS  PubMed  Google Scholar 

  23. Liamis G, Milionis H, Elisaf M (2008) A review of drug-induced hyponatremia. Am J Kidney Dis 52(1):144–153

    Article  CAS  PubMed  Google Scholar 

  24. Doshi SM, Shah P, Lei X, Lahoti A, Salahudeen AK (2012) Hyponatremia in hospitalized cancer patients and its impact on clinical outcomes. Am J Kidney Dis 59(2):222–228

    Article  CAS  PubMed  Google Scholar 

  25. Sterns RH, Silver SM, Hix JK (2015) Urea for hyponatremia? Kidney Int 87(2):268–270

    Article  PubMed  Google Scholar 

  26. Decaux G, Unger J, Brimioulle S, Mockel J (1982) Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247(4):471–474

    Article  CAS  PubMed  Google Scholar 

  27. Decaux G, Andres C, Gankam Kengne F, Soupart A (2010) Treatment of euvolemic hyponatremia in the intensive care unit by urea. Crit Care 14(5):R184

    Article  PubMed  PubMed Central  Google Scholar 

  28. Soupart A, Coffernils M, Couturier B, Gankam-Kengne F, Decaux G (2012) Efficacy and tolerance of urea compared with vaptans for long-term treatment of patients with SIADH. Clin J Am Soc Nephrol 7(5):742–747

    Article  CAS  PubMed  Google Scholar 

  29. Petereit C, Zaba O, Teber I, Luders H, Grohe C (2013) A rapid and efficient way to manage hyponatremia in patients with SIADH and small cell lung cancer: treatment with tolvaptan. BMC Pulm Med 13:55

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Verbalis JG (2010) Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol Nutr 57(Suppl 2):30–40

    Article  PubMed  Google Scholar 

  31. Berardi R, Caramanti M, Castagnani M, Guglielmi S, Marcucci F, Savini A et al (2015) Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. Support Care Cancer 23(10):3095–3101

    Article  CAS  PubMed  Google Scholar 

  32. Berl T (2013) An elderly patient with chronic hyponatremia. Clin J Am Soc Nephrol 8(3):469–475

    Article  PubMed  Google Scholar 

  33. Mannesse CK, Vondeling AM, van Marum RJ, van Solinge WW, Egberts TC, Jansen PA (2013) Prevalence of hyponatremia on geriatric wards compared to other settings over four decades: a systematic review. Ageing Res Rev 12(1):165–173

    Article  CAS  PubMed  Google Scholar 

  34. Soiza RL, Cumming K, Clarke JM, Wood KM, Myint PK (2014) Hyponatremia: special considerations in older patients. J Clin Med 3(3):944–958

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Shapiro DS, Sonnenblick M, Galperin I, Melkonyan L, Munter G (2010) Severe hyponatraemia in elderly hospitalized patients: prevalence, aetiology and outcome. Intern Med J 40(8):574–580

    Article  CAS  PubMed  Google Scholar 

  36. Beck LH (1998) Changes in renal function with aging. Clin Geriatr Med 14(2):199–209

    CAS  PubMed  Google Scholar 

  37. Lindeman RD, Tobin J, Shock NW (1985) Longitudinal studies on the rate of decline in renal function with age. J Am Geriatr Soc 33(4):278–285

    Article  CAS  PubMed  Google Scholar 

  38. Moran D, Fronk C, Mandel E (2014) Managing hyponatremia in adults. JAAPA 27(4):23–29 (quiz 30)

    PubMed  Google Scholar 

  39. Kugler JP, Hustead T (2000) Hyponatremia and hypernatremia in the elderly. Am Fam Physician 61(12):3623–3630

    CAS  PubMed  Google Scholar 

  40. Wannamethee SG, Shaper AG, Lennon L, Papacosta O, Whincup P (2016) Mild hyponatremia, hypernatremia and incident cardiovascular disease and mortality in older men: a population-based cohort study. Nutr Metab Cardiovasc Dis 26(1):12–19

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Hoyle GE, Chua M, Soiza RL (2011) Volaemic assessment of the elderly hyponatraemic patient: reliability of clinical assessment and validation of bioelectrical impedance analysis. QJM 104(1):35–39

    Article  CAS  PubMed  Google Scholar 

  42. De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F et al (2005) Hyponatremia in patients with heart failure. Am J Cardiol 96(12A):19L–23L

    Article  PubMed  CAS  Google Scholar 

  43. Gheorghiade M, Abraham WT, Albert NM, Gattis Stough W, Greenberg BH, O’Connor CM et al (2007) Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registry. Eur Heart J 28(8):980–988

    Article  CAS  PubMed  Google Scholar 

  44. Friedewald VE, Emmett M, Gheorghiade M, Roberts WC (2011) The editor’s roundtable: pathophysiology and management of hyponatremia and the role of vasopressin antagonists. Am J Cardiol 107(9):1357–1364

    Article  PubMed  Google Scholar 

  45. Farmakis D, Filippatos G, Parissis J, Kremastinos DT, Gheorghiade M (2009) Hyponatremia in heart failure. Heart Fail Rev 14(2):59–63

    Article  PubMed  Google Scholar 

  46. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Pina IL et al (2007) Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med 167(18):1998–2005

    Article  PubMed  Google Scholar 

  47. Wald R, Jaber BL, Price LL, Upadhyay A, Madias NE (2010) Impact of hospital-associated hyponatremia on selected outcomes. Arch Intern Med 170(3):294–302

    Article  CAS  PubMed  Google Scholar 

  48. Urso C, Brucculeri S, Caimi G (2015) Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications. Heart Fail Rev 20(4):493–503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Bettari L, Fiuzat M, Shaw LK, Wojdyla DM, Metra M, Felker GM et al (2012) Hyponatremia and long-term outcomes in chronic heart failure—an observational study from the Duke Databank for Cardiovascular Diseases. J Card Fail. 18(1):74–81

    Article  CAS  PubMed  Google Scholar 

  50. Konishi M, Haraguchi G, Ohigashi H, Sasaoka T, Yoshikawa S, Inagaki H et al (2012) Progression of hyponatremia is associated with increased cardiac mortality in patients hospitalized for acute decompensated heart failure. J Card Fail. 18(8):620–625

    Article  CAS  PubMed  Google Scholar 

  51. De Vecchis R, Di Maio M, Di Biase G, Ariano C (2016) Effects of hyponatremia normalization on the short-term mortality and rehospitalizations in patients with recent acute decompensated heart failure: a retrospective study. J Clin Med 5(10):92

    Article  PubMed Central  Google Scholar 

  52. Konstam MA, Gheorghiade M, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K et al (2007) Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297(12):1319–1331

    Article  CAS  PubMed  Google Scholar 

  53. Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM et al (2007) Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial. Acute Card Care 9(2):82–86

    Article  PubMed  Google Scholar 

  54. Hauptman PJ, Burnett J, Gheorghiade M, Grinfeld L, Konstam MA, Kostic D et al (2013) Clinical course of patients with hyponatremia and decompensated systolic heart failure and the effect of vasopressin receptor antagonism with tolvaptan. J Card Fail 19(6):390–397

    Article  CAS  PubMed  Google Scholar 

  55. Schrier RW, Gross P, Gheorghiade M, Berl T, Verbalis JG, Czerwiec FS et al (2006) Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355(20):2099–2112

    Article  CAS  PubMed  Google Scholar 

  56. Felker GM, Mentz RJ, Adams KF, Cole RT, Egnaczyk GF, Patel CB et al (2015) Tolvaptan in patients hospitalized with acute heart failure: rationale and design of the TACTICS and the SECRET of CHF Trials. Circ Heart Fail 8(5):997–1005

    Article  CAS  PubMed  Google Scholar 

  57. Angeli P, Wong F, Watson H, Gines P, Investigators C (2006) Hyponatremia in cirrhosis: results of a patient population survey. Hepatology 44(6):1535–1542

    Article  CAS  PubMed  Google Scholar 

  58. Gines P, Berl T, Bernardi M, Bichet DG, Hamon G, Jimenez W et al (1998) Hyponatremia in cirrhosis: from pathogenesis to treatment. Hepatology 28(3):851–864

    Article  CAS  PubMed  Google Scholar 

  59. Gines P, Guevara M (2008) Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management. Hepatology 48(3):1002–1010

    Article  CAS  PubMed  Google Scholar 

  60. Fukui H (2015) Do vasopressin V2 receptor antagonists benefit cirrhotics with refractory ascites? World J Gastroenterol 21(41):11584–11596

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT et al (2008) Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med 359(10):1018–1026

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Guyader D, Patat A, Ellis-Grosse EJ, Orczyk GP (2002) Pharmacodynamic effects of a nonpeptide antidiuretic hormone V2 antagonist in cirrhotic patients with ascites. Hepatology 36(5):1197–1205

    Article  CAS  PubMed  Google Scholar 

  63. Gines P, Wong F, Watson H, Terg R, Bruha R, Zarski JP et al (2010) Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia—a randomized, double-blind, placebo-controlled study. Aliment Pharmacol Ther 31(8):834–845

    CAS  PubMed  Google Scholar 

  64. Wong F, Gines P, Watson H, Horsmans Y, Angeli P, Gow P et al (2010) Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis. J Hepatol 53(2):283–290

    Article  CAS  PubMed  Google Scholar 

  65. Wong F, Watson H, Gerbes A, Vilstrup H, Badalamenti S, Bernardi M et al (2012) Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity. Gut 61(1):108–116

    Article  CAS  PubMed  Google Scholar 

  66. Gerbes AL, Gulberg V, Gines P, Decaux G, Gross P, Gandjini H et al (2003) Therapy of hyponatremia in cirrhosis with a vasopressin receptor antagonist: a randomized double-blind multicenter trial. Gastroenterology 124(4):933–939

    Article  CAS  PubMed  Google Scholar 

  67. Okita K, Kawazoe S, Hasebe C, Kajimura K, Kaneko A, Okada M et al (2014) Dose-finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: a randomized, double-blind, placebo-controlled trial. Hepatol Res. 44(1):83–91

    Article  CAS  PubMed  Google Scholar 

  68. Sakaida I, Kawazoe S, Kajimura K, Saito T, Okuse C, Takaguchi K et al (2014) Tolvaptan for improvement of hepatic edema: a phase 3, multicenter, randomized, double-blind, placebo-controlled trial. Hepatol Res 44(1):73–82

    Article  CAS  PubMed  Google Scholar 

  69. Watkins PB, Lewis JH, Kaplowitz N, Alpers DH, Blais JD, Smotzer DM et al (2015) Clinical pattern of tolvaptan-associated liver injury in subjects with autosomal dominant polycystic kidney disease: analysis of clinical trials database. Drug Saf 38(11):1103–1113

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Kovesdy CP, Lott EH, Lu JL, Malakauskas SM, Ma JZ, Molnar MZ et al (2012) Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation 125(5):677–684

    Article  PubMed  PubMed Central  Google Scholar 

  71. Dimitriadis C, Sekercioglu N, Pipili C, Oreopoulos D, Bargman JM (2014) Hyponatremia in peritoneal dialysis: epidemiology in a single center and correlation with clinical and biochemical parameters. Perit Dial Int 34(3):260–270

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. Khan S, Floris M, Pani A, Rosner MH (2016) Sodium and volume disorders in advanced chronic kidney disease. Adv Chronic Kidney Dis 23(4):240–246

    Article  PubMed  Google Scholar 

  73. Negro A, Regolisti G, Perazzoli F, Davoli S, Sani C, Rossi E (1998) Ifosfamide-induced renal Fanconi syndrome with associated nephrogenic diabetes insipidus in an adult patient. Nephrol Dial Transplant 13(6):1547–1549

    Article  CAS  PubMed  Google Scholar 

  74. Combs S, Berl T (2014) Dysnatremias in patients with kidney disease. Am J Kidney Dis 63(2):294–303

    Article  CAS  PubMed  Google Scholar 

  75. Waikar SS, Curhan GC, Brunelli SM (2011) Mortality associated with low serum sodium concentration in maintenance hemodialysis. Am J Med 124(1):77–84

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Nigwekar SU, Wenger J, Thadhani R, Bhan I (2013) Hyponatremia, mineral metabolism, and mortality in incident maintenance hemodialysis patients: a cohort study. Am J Kidney Dis 62(4):755–762

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  77. Hecking M, Karaboyas A, Saran R, Sen A, Inaba M, Rayner H et al (2012) Dialysate sodium concentration and the association with interdialytic weight gain, hospitalization, and mortality. Clin J Am Soc Nephrol 7(1):92–100

    Article  CAS  PubMed  Google Scholar 

  78. Tanaka A, Katsuno T, Ozaki T, Sakata F, Kato N, Suzuki Y et al (2015) The efficacy of tolvaptan as a diuretic for chronic kidney disease patients. Acta Cardiol 70(2):217–223

    Article  PubMed  Google Scholar 

  79. Dangoisse C, Dickie H, Tovey L, Ostermann M (2014) Correction of hyper- and hyponatraemia during continuous renal replacement therapy. Nephron Clin Pract 128(3–4):394–398

    CAS  PubMed  Google Scholar 

  80. Wendland EM, Kaplan AA (2012) A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease. Semin Dial 25(1):82–85

    Article  PubMed  Google Scholar 

  81. Ball SG, Iqbal Z (2016) Diagnosis and treatment of hyponatraemia. Best Pract Res Clin Endocrinol Metab 30(2):161–173

    Article  CAS  PubMed  Google Scholar 

  82. Gisby M, Lundberg J, Landin M, O’Reilly K, Robinson P, Sobocki P et al (2016) The burden of illness in patients with hyponatraemia in Sweden: a population-based registry study. Int J Clin Pract 70(4):319–329

    Article  CAS  PubMed  Google Scholar 

  83. Rodrigues B, Staff I, Fortunato G, McCullough LD (2014) Hyponatremia in the prognosis of acute ischemic stroke. J Stroke Cerebrovasc Dis 23(5):850–854

    Article  PubMed  Google Scholar 

  84. Hiew FL, Winer JB, Rajabally YA (2016) Hyponatraemia in Guillain–Barre syndrome revisited. Acta Neurol Scand 133(4):295–301

    Article  CAS  PubMed  Google Scholar 

  85. Holland-Bill L, Christiansen CF, Heide-Jorgensen U, Ulrichsen SP, Ring T, Jorgensen JO et al (2015) Hyponatremia and mortality risk: a Danish cohort study of 279 508 acutely hospitalized patients. Eur J Endocrinol 173(1):71–81

    Article  CAS  PubMed  Google Scholar 

  86. Sherlock M, O’Sullivan E, Agha A, Behan LA, Owens D, Finucane F et al (1002) Incidence and pathophysiology of severe hyponatraemia in neurosurgical patients. Postgrad Med J 2009(85):171–175

    Google Scholar 

  87. Mapa B, Taylor BE, Appelboom G, Bruce EM, Claassen J, Connolly ES Jr (2016) Impact of hyponatremia on morbidity, mortality, and complications after aneurysmal subarachnoid hemorrhage: a systematic review. World Neurosurg 85:305–314

    Article  PubMed  Google Scholar 

  88. Kelly DF, Laws ER Jr, Fossett D (1995) Delayed hyponatremia after transsphenoidal surgery for pituitary adenoma. Report of nine cases. J Neurosurg 83(2):363–367

    Article  CAS  PubMed  Google Scholar 

  89. Kristof RA, Rother M, Neuloh G, Klingmuller D (2009) Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg 111(3):555–562

    Article  PubMed  Google Scholar 

  90. Olson BR, Rubino D, Gumowski J, Oldfield EH (1995) Isolated hyponatremia after transsphenoidal pituitary surgery. J Clin Endocrinol Metab 80(1):85–91

    CAS  PubMed  Google Scholar 

  91. Bales J, Cho S, Tran TK, Korab GA, Khandelwal N, Spiekerman CF et al (2016) The effect of hyponatremia and sodium variability on outcomes in adults with aneurysmal subarachnoid hemorrhage. World Neurosurg 96:340–349

    Article  PubMed  Google Scholar 

  92. Williams C, Simon TD, Riva-Cambrin J, Bratton SL (2012) Hyponatremia with intracranial malignant tumor resection in children. J Neurosurg Pediatr 9(5):524–529

    Article  PubMed  PubMed Central  Google Scholar 

  93. Kao L, Al-Lawati Z, Vavao J, Steinberg GK, Katznelson L (2009) Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Pituitary 12(4):347–351

    Article  PubMed  Google Scholar 

  94. Palmer BF (2003) Hyponatremia in patients with central nervous system disease: SIADH versus CSW. Trends Endocrinol Metab 14(4):182–187

    Article  CAS  PubMed  Google Scholar 

  95. Loh JA, Verbalis JG (2007) Diabetes insipidus as a complication after pituitary surgery. Nat Clin Pract Endocrinol Metab 3(6):489–494

    Article  PubMed  Google Scholar 

  96. Zhang L, Fu P, Wang L, Cai G, Zhang L, Chen D et al (2013) Hyponatraemia in patients with crush syndrome during the Wenchuan earthquake. Emerg Med J. 30(9):745–748

    Article  CAS  PubMed  Google Scholar 

  97. Roquilly A, Mahe PJ, Seguin P, Guitton C, Floch H, Tellier AC et al (2011) Hydrocortisone therapy for patients with multiple trauma: the randomized controlled HYPOLYTE study. JAMA 305(12):1201–1209

    Article  CAS  PubMed  Google Scholar 

  98. Aqil A, Hossain F, Sheikh H, Aderinto J, Whitwell G, Kapoor H (2016) Achieving hip fracture surgery within 36 hours: an investigation of risk factors to surgical delay and recommendations for practice. J Orthop Traumatol 17(3):207–213

    Article  PubMed  Google Scholar 

  99. Sharif S, Dominguez M, Imbriano L, Mattana J, Maesaka JK (2015) Recognition of hyponatremia as a risk factor for hip fractures in older persons. J Am Geriatr Soc 63(9):1962–1964

    Article  PubMed  Google Scholar 

  100. Murthy K, Koshkina O, Marcantonio AJ, Pala N, Breeze JL, Paulus J et al (2015) Hyponatremia and fracture risk: a hospital-based case–control study. J Am Geriatr Soc 63(8):1699–1701

    Article  PubMed  Google Scholar 

  101. Usala RL, Fernandez SJ, Mete M, Cowen L, Shara NM, Barsony J et al (2015) hyponatremia is associated with increased osteoporosis and bone fractures in a large US health system population. J Clin Endocrinol Metab 100(8):3021–3031

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Hawkins RC (2003) Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta 337(1–2):169–172

    Article  CAS  PubMed  Google Scholar 

  103. Tasdemir V, Oguz AK, Sayin I, Ergun I (2015) Hyponatremia in the outpatient setting: clinical characteristics, risk factors, and outcome. Int Urol Nephrol 47(12):1977–1983

    Article  PubMed  Google Scholar 

  104. Liamis G, Rodenburg EM, Hofman A, Zietse R, Stricker BH, Hoorn EJ (2013) Electrolyte disorders in community subjects: prevalence and risk factors. Am J Med 126(3):256–263

    Article  CAS  PubMed  Google Scholar 

  105. Gankam-Kengne F, Ayers C, Khera A, de Lemos J, Maalouf NM (2013) Mild hyponatremia is associated with an increased risk of death in an ambulatory setting. Kidney Int 83(4):700–706

    Article  CAS  PubMed  Google Scholar 

  106. Liamis G, Filippatos TD, Elisaf MS (2016) Thiazide-associated hyponatremia in the elderly: what the clinician needs to know. J Geriatr Cardiol 13(2):175–182

    PubMed  PubMed Central  Google Scholar 

  107. Sajadieh A, Binici Z, Mouridsen MR, Nielsen OW, Hansen JF, Haugaard SB (2009) Mild hyponatremia carries a poor prognosis in community subjects. Am J Med 122(7):679–686

    Article  PubMed  Google Scholar 

  108. Hoorn EJ, Rivadeneira F, van Meurs JB, Ziere G, Stricker BH, Hofman A et al (2011) Mild hyponatremia as a risk factor for fractures: the Rotterdam study. J Bone Miner Res 26(8):1822–1828

    Article  CAS  PubMed  Google Scholar 

  109. Verbalis JG, Adler S, Schrier RW, Berl T, Zhao Q, Czerwiec FS et al (2011) Efficacy and safety of oral tolvaptan therapy in patients with the syndrome of inappropriate antidiuretic hormone secretion. Eur J Endocrinol 164(5):725–732

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  110. De las Penas R, Ponce S, Henao F, Camps Herrero C, Carcereny E, Escobar Alvarez Y et al (2016) SIADH-related hyponatremia in hospital day care units: clinical experience and management with tolvaptan. Support Care Cancer. 24(1):499–507

    Article  PubMed  Google Scholar 

  111. Almond CS, Shin AY, Fortescue EB, Mannix RC, Wypij D, Binstadt BA et al (2005) Hyponatremia among runners in the Boston Marathon. N Engl J Med 352(15):1550–1556

    Article  CAS  PubMed  Google Scholar 

  112. Ben-Abraham R, Szold O, Rudick V, Weinbroum AA (2003) ‘Ecstasy’ intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting. Eur J Emerg Med 10(4):309–313

    Article  PubMed  Google Scholar 

  113. Arieff AI (1984) Central nervous system manifestations of disordered sodium metabolism. Clin Endocrinol Metab 13(2):269–294

    Article  CAS  PubMed  Google Scholar 

  114. Berl T (1990) Treating hyponatremia: what is all the controversy about? Ann Intern Med 113(6):417–419

    Article  CAS  PubMed  Google Scholar 

  115. Edelman IS, Leibman J, O’Meara MP, Birkenfeld LW (1958) Interrelations between serum sodium concentration, serum osmolarity and total exchangeable sodium, total exchangeable potassium and total body water. J Clin Invest 37(9):1236–1256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  116. Sterns RH, Hix JK, Silver S (2010) Treating profound hyponatremia: a strategy for controlled correction. Am J Kidney Dis 56(4):774–779

    Article  CAS  PubMed  Google Scholar 

  117. Hanna RM, Yang WT, Lopez EA, Riad JN, Wilson J (2016) The utility and accuracy of four equations in predicting sodium levels in dysnatremic patients. Clin Kidney J 9(4):530–539

    Article  PubMed  PubMed Central  Google Scholar 

  118. Trepiccione F, Capasso G, Lippi G (2014) Serum and urine osmolality: clinical and laboratory features. G Ital Nefrol 31(5)

  119. Corona G, Giuliani C, Verbalis JG, Forti G, Maggi M, Peri A (2015) Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 10(4):e0124105

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  120. Ellison DH, Berl T (2007) Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med 356(20):2064–2072

    Article  CAS  PubMed  Google Scholar 

  121. Grohe C, Berardi R, Burst V (2015) Hyponatraemia–SIADH in lung cancer diagnostic and treatment algorithms. Crit Rev Oncol Hematol 96(1):1–8

    Article  PubMed  Google Scholar 

  122. Onitilo AA, Kio E, Doi SA (2007) Tumor-related hyponatremia. Clin Med Res 5(4):228–237

    Article  PubMed  PubMed Central  Google Scholar 

  123. Berardi R, Rinaldi S, Caramanti M, Grohe C, Santoni M, Morgese F et al (2016) Hyponatremia in cancer patients: time for a new approach. Crit Rev Oncol Hematol 102:15–25

    Article  PubMed  Google Scholar 

  124. Berardi R, Santoni M, Rinaldi S, Nunzi E, Smerilli A, Caramanti M et al (2016) Risk of hyponatraemia in cancer patients treated with targeted therapies: a systematic review and meta-analysis of clinical trials. PLoS One 11(5):e0152079

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  125. Illouz F, Braun D, Briet C, Schweizer U, Rodien P (2014) Endocrine side-effects of anti-cancer drugs: thyroid effects of tyrosine kinase inhibitors. Eur J Endocrinol 171(3):R91–R99

    Article  CAS  PubMed  Google Scholar 

  126. Lu X, Wang X (2017) Hyponatremia induced by antiepileptic drugs in patients with epilepsy. Expert Opin Drug Saf 16(1):77–87

    Article  CAS  PubMed  Google Scholar 

  127. Tsapepas D, Chiles M, Babayev R, Rao MK, Jaitly M, Salerno D et al (2016) Incidence of hyponatremia with high-dose trimethoprim-sulfamethoxazole exposure. Am J Med 129(12):1322–1328

    Article  CAS  PubMed  Google Scholar 

  128. Tanaka R, Suzuki Y, Takumi Y, Iwao M, Sato Y, Hashinaga K et al (2016) A retrospective analysis of risk factors for linezolid-associated hyponatremia in Japanese patients. Biol Pharm Bull 39(12):1968–1973

    Article  CAS  PubMed  Google Scholar 

  129. Spital A (1999) Diuretic-induced hyponatremia. Am J Nephrol 19(4):447–452

    Article  CAS  PubMed  Google Scholar 

  130. Gandhi S, Shariff SZ, Al-Jaishi A, Reiss JP, Mamdani MM, Hackam DG et al (2017) Second-generation antidepressants and hyponatremia risk: a population-based cohort study of older adults. Am J Kidney Dis 69(1):87–96

    Article  CAS  PubMed  Google Scholar 

  131. Buon M, Gaillard C, Martin J, Fedrizzi S, Mosquet B, Coquerel A et al (2013) Risk of proton pump inhibitor-induced mild hyponatremia in older adults. J Am Geriatr Soc 61(11):2052–2054

    Article  PubMed  Google Scholar 

  132. Izzedine H, Fardet L, Launay-Vacher V, Dorent R, Petitclerc T, Deray G (2002) Angiotensin-converting enzyme inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone: case report and review of the literature. Clin Pharmacol Ther 71(6):503–507

    Article  PubMed  Google Scholar 

  133. Yamada H, Asano T, Aoki A, Ikoma A, Yoshida M, Kusaka I et al (2014) Combination therapy of angiotensin II receptor blocker and thiazide produces severe hyponatremia in elderly hypertensive subjects. Intern Med 53(7):749–752

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank all the members of the Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology, for the scientific support during the writing of the manuscript.

Author information

Author notes

  1. E. Sbardella and A. M. Isidori contributed equally to this work.

Authors and Affiliations

  1. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

    E. Sbardella, A. M. Isidori & A. Lenzi

  2. Clinica di Endocrinologia e Malattie del Metabolismo, Università Politecnica delle Marche Azienda Ospedaliero-Universitaria, Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy

    G. Arnaldi

  3. Endocrinology and Diabetology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy

    M. Arosio & G. Mantovani

  4. UOC di Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy

    C. Barone

  5. Division of Endocrinology, Diabetes and Metabolism, Department of Medical Sciences, University of Turin, Turin, Italy

    A. Benso

  6. Clinica Oncologica, Università Politecnica delle Marche Azienda Ospedaliero-Universitaria; Ospedali Riuniti Umberto I-GM Lancisi-G Salesi, Ancona, Italy

    R. Berardi

  7. Dipartimento di Scienze Cardio-Toraciche e Respiratorie, Università della Campania “Luigi Vanvitelli”, Caserta, Italy

    G. Capasso & F. Trepiccione

  8. Laboratory of Cardiovascular Endocrinology, IRCCS San Raffaele Pisana, Rome, Italy

    M. Caprio

  9. Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open University, Rome, Italy

    M. Caprio

  10. Endocrinology Unit, Department of Medicine DIMED, University-Hospital of Padova, Padua, Italy

    F. Ceccato & C. Scaroni

  11. Endocrinology Unit, Medical Department, Azienda Usl Bologna Maggiore-Bellaria Hospital, Bologna, Italy

    G. Corona

  12. Endocrinology and Metabolic Diseases Unit, Catholic University of the Sacred Heart, Rome, Italy

    S. Della Casa

  13. Nephrology, Medical School, University of Campania Luigi Vanvitelli, Naples, Italy

    L. De Nicola

  14. Pituitary Unit, IRCCS Institute of Neurological Sciences, Bellaria Hospital, Bologna, Italy

    M. Faustini-Fustini

  15. Renal Unit, Parma University Medical School, Parma, Italy

    E. Fiaccadori & G. Regolisti

  16. Nephrology Dialysis and Transplantation, Bari University Medical School, Bari, Italy

    L. Gesualdo

  17. UOC Oncologia Medica, Ospedale Sacro Cuore Don Calabria, Negrar, Verona, Italy

    S. Gori

  18. Endocrine Unit, Department of Biomedical Sciences, Humanitas Research Hospital, Humanitas University, Rozzano (MI), Italy

    A. Lania

  19. Nephrology, Sapienza University of Rome, Rome, Italy

    P. Menè

  20. Endocrine Unit, Careggi Hospital, Florence, Italy

    G. Parenti

  21. Oncologia Medica IRCCS Arcispedale S. Maria Nuova, Reggio Emilia, Italy

    C. Pinto

  22. Dipartimento di Medicina Clinica e Chirurgia, Sezione di Endocrinologia, Università “Federico II” di Napoli, Naples, Italy

    R. Pivonello

  23. Endocrine Unit, AO Ordine Mauriziano, Turin, Italy

    P. Razzore

  24. Endocrine Unit, Department of Experimental and Clinical Biomedical Sciences “Mario Serio”, AOU Careggi, University of Florence, Viale Pieraccini, 6, 50139, Florence, Italy

    A. Peri

Authors
  1. E. Sbardella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. M. Isidori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Arnaldi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Arosio
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C. Barone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Benso
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Berardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. G. Capasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Caprio
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Ceccato
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. G. Corona
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. S. Della Casa
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. L. De Nicola
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. M. Faustini-Fustini
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. E. Fiaccadori
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. L. Gesualdo
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. S. Gori
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. A. Lania
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. G. Mantovani
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. P. Menè
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. G. Parenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. C. Pinto
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. R. Pivonello
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. P. Razzore
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. G. Regolisti
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. C. Scaroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. F. Trepiccione
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. A. Lenzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. A. Peri
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

On behalf of the: Fluid and Electrolyte Disorders Club of the Italian Society of Endocrinology; Italian Society of Nephrology; and Italian Association of Medical Oncology

Corresponding author

Correspondence to A. Peri.

Ethics declarations

Conflict of interest

A.M.I. has been an occasional consultant for Shire and Novartis; R.B. has been an occasional consultant for Otsuka; G.M. has been an occasional consultant for Shire and Novartis; A.L. has been an occasional consultant for Shire and Novartis; A.P. has been an occasional consultant for Otsuka. All other authors have nothing to disclose.

Funding

The study was not funded.

Ethical approval

This consensus statement does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

No informed consent needed.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sbardella, E., Isidori, A.M., Arnaldi, G. et al. Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM). J Endocrinol Invest 41, 3–19 (2018). https://doi.org/10.1007/s40618-017-0776-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-017-0776-x

Search

Navigation